Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Osteitis Deformans × Lapatinib × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Neoplasms 3 Neoplasm Metastasis 3 Stomach Neoplasms 1 Sarcoma 1 Osteitis Deformans 1 Neoplastic Cells, Circulating 1 Invasive Breast Cancer 1 Head and Neck Neoplasms 1 HER2-positive Advanced Breast Cancer 1 HER2+ Metastatic Breast Cancer (MBC) 1 HER2 Positive Metastatic Breast Cancer 1 Esophageal Neoplasms 1 Carcinoma 1 Breast Neoplasms, Male 1 Brain Neoplasms 1

Interventions

ribociclib 1 Trastuzumab 1 Paclitaxel 1 Letrozole 1 Lapatinib 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00553358 2021-09-21

Neo ALTTO

Novartis

Phase 3 Completed

455 enrolled 34 charts

Breast Neoplasms, Osteitis Deformans

Data powered by HemOnc (CC BY 4.0) Colophon ⚡